IS4924A - Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum - Google Patents

Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum

Info

Publication number
IS4924A
IS4924A IS4924A IS4924A IS4924A IS 4924 A IS4924 A IS 4924A IS 4924 A IS4924 A IS 4924A IS 4924 A IS4924 A IS 4924A IS 4924 A IS4924 A IS 4924A
Authority
IS
Iceland
Prior art keywords
treatment
acetic acid
acid derivatives
thrombotic disorders
piperidine acetic
Prior art date
Application number
IS4924A
Other languages
English (en)
Icelandic (is)
Inventor
George Allen David
David Eldred Colin
Leonard Mitchell William
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4924A publication Critical patent/IS4924A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4924A 1996-06-21 1998-12-15 Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum IS4924A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
PCT/EP1997/003196 WO1997049699A1 (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Publications (1)

Publication Number Publication Date
IS4924A true IS4924A (is) 1998-12-15

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4924A IS4924A (is) 1996-06-21 1998-12-15 Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum

Country Status (17)

Country Link
EP (1) EP0912555A1 (id)
JP (1) JP2000512648A (id)
KR (1) KR20000022041A (id)
AP (1) AP9801417A0 (id)
AR (1) AR008245A1 (id)
AU (1) AU3261197A (id)
BR (1) BR9709930A (id)
CA (1) CA2258753A1 (id)
CZ (1) CZ424698A3 (id)
EA (1) EA199801015A1 (id)
ID (1) ID17052A (id)
IL (1) IL127464A0 (id)
IS (1) IS4924A (id)
NO (1) NO985974L (id)
PL (1) PL330797A1 (id)
TR (1) TR199802665T2 (id)
WO (1) WO1997049699A1 (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
JP2004536113A (ja) 2001-07-03 2004-12-02 カイロン コーポレイション チロシンキナーゼおよびセリン／スレオニンキナーゼのインヒビターとしてのインダゾールベンズイミダゾール化合物
TW200401641A (en) * 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
CN100422171C (zh) * 2003-02-14 2008-10-01 惠氏公司 作为5-羟色胺-6配体的杂环-3-磺酰基吲唑
BRPI0709718A2 (pt) 2006-04-05 2011-03-29 Wyeth Corp composto; método para tratamento de um transtorno do sistema nervoso central relacionado a ou afetado pelo receptor 5-ht6 em um paciente necessitado; composição farmacêutica; e proceso para a preparação do composto
JP5208963B2 (ja) 2007-01-10 2013-06-12 エフ．ホフマン−ラ ロシュ アーゲー キマーゼ阻害剤としてのスルホンアミド誘導体
CN113655155A (zh) * 2021-07-28 2021-11-16 任贤金 一种测定sph3127有关物质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH07501063A (ja) * 1991-11-14 1995-02-02 グラクソ、グループ、リミテッド フィブリノーゲン依存性血小板凝集阻害剤としてのピペリジン酢酸誘導体
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
EP0912555A1 (en) 1999-05-06
NO985974D0 (no) 1998-12-18
AP9801417A0 (en) 1998-12-31
JP2000512648A (ja) 2000-09-26
CZ424698A3 (cs) 1999-05-12
EA199801015A1 (ru) 1999-08-26
BR9709930A (pt) 1999-08-10
KR20000022041A (ko) 2000-04-25
NO985974L (no) 1999-02-17
IL127464A0 (en) 1999-10-28
AU3261197A (en) 1998-01-14
ID17052A (id) 1997-12-04
CA2258753A1 (en) 1997-12-31
PL330797A1 (en) 1999-06-07
TR199802665T2 (xx) 1999-03-22
AR008245A1 (es) 1999-12-29
WO1997049699A1 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
NO990700D0 (no) Propionsyrederivater og anvendelsen herav
FI970771L (fi) Uusia allergisten sairauksien hoidossa käyttökelpoisia substituoituja piperidiinejä
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO2008002I2 (no) Protiokonazol og salter derav
NO20001754L (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
DE69813570D1 (de) 5-alkyl-2-arylaminophenylessigsäure und derivative
NO953991D0 (no) Ultrasomisk og elektro-kirurgisk håndstykke av piezotype
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
IS4481A (is) Díhýdrópyramídín og notkun þeirra
DK0741594T3 (da) Fototermisk terapeutisk anordning og metode
FI953838L (fi) Imidatsopyriidineja ja niiden käyttö maha-suolisairauksien hoidossa
EE05067B1 (et) Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
FI940216A0 (fi) Kinoloni- ja naftyridonikarboksyylihappojohdannaiset
NO975439D0 (no) Ketonderivater og medisinsk anvendelse derav
IS5021A (is) Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum
FI951101A0 (fi) 5-vinyyli- ja 5-etinyylikinoloni- ja -naftyridonikarboksyylihapot
ID22841A (id) Penggunaan larutan-larutan asam manonatrium iminodiasetat di dalam pembuatan asam n-fosfonometiliminodiasetat
AU3261097A (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
FI971193L (fi) Hoidossa käyttökelpoisia kinoksaliinijohdannaisia
FI954138A7 (fi) Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä
IL127464A0 (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
FI954680A7 (fi) Kinoloni- ja naftyridonikarboksyylihappojohdannaiset